These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9676890)

  • 1. [123I]beta-CIT SPECT imaging of dopamine transporter availability after mazindol administration in human cocaine addicts.
    Malison RT; McCance E; Carpenter LL; Baldwin RM; Seibyl JP; Price LH; Kosten TR; Innis RB
    Psychopharmacology (Berl); 1998 Jun; 137(4):321-5. PubMed ID: 9676890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Euphorigenic doses of cocaine reduce [123I]beta-CIT SPECT measures of dopamine transporter availability in human cocaine addicts.
    Malison RT; Best SE; Wallace EA; McCance E; Laruelle M; Zoghbi SS; Baldwin RM; Seibyl JS; Hoffer PB; Price LH
    Psychopharmacology (Berl); 1995 Dec; 122(4):358-62. PubMed ID: 8657833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.
    Seibyl JP; Laruelle M; van Dyck CH; Wallace E; Baldwin RM; Zoghbi S; Zea-Ponce Y; Neumeyer JL; Charney DS; Hoffer PB; Innis RB
    J Nucl Med; 1996 Feb; 37(2):222-8. PubMed ID: 8667048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodine-123 labelled N-(2-fluoroethyl)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)nortropane for dopamine transporter imaging in the living human brain.
    Kuikka JT; Akerman K; Bergström KA; Karhu J; Hiltunen J; Haukka J; Heikkinen J; Tiihonen J; Wang S; Neumeyer JL
    Eur J Nucl Med; 1995 Jul; 22(7):682-6. PubMed ID: 7498231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations.
    Villemagne V; Yuan J; Wong DF; Dannals RF; Hatzidimitriou G; Mathews WB; Ravert HT; Musachio J; McCann UD; Ricaurte GA
    J Neurosci; 1998 Jan; 18(1):419-27. PubMed ID: 9412518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and 2 beta-carbomethoxy-3 beta-(4-iodophenyl)-N-(3-fluoropropyl)nortropane for imaging of the dopamine transporter in the living human brain.
    Kuikka JT; Bergström KA; Ahonen A; Hiltunen J; Haukka J; Länsimies E; Wang S; Neumeyer JL
    Eur J Nucl Med; 1995 Apr; 22(4):356-60. PubMed ID: 7607268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.
    Laruelle M; Baldwin RM; Malison RT; Zea-Ponce Y; Zoghbi SS; al-Tikriti MS; Sybirska EH; Zimmermann RC; Wisniewski G; Neumeyer JL
    Synapse; 1993 Apr; 13(4):295-309. PubMed ID: 7683143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.
    Pirker W; Asenbaum S; Hauk M; Kandlhofer S; Tauscher J; Willeit M; Neumeister A; Praschak-Rieder N; Angelberger P; Brücke T
    J Nucl Med; 2000 Jan; 41(1):36-44. PubMed ID: 10647603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT.
    Abi-Dargham A; Gandelman MS; DeErausquin GA; Zea-Ponce Y; Zoghbi SS; Baldwin RM; Laruelle M; Charney DS; Hoffer PB; Neumeyer JL; Innis RB
    J Nucl Med; 1996 Jul; 37(7):1129-33. PubMed ID: 8965183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of striatal dopamine transporter function in rats by in vivo beta-[123I]CIT pinhole SPECT.
    Scherfler C; Donnemiller E; Schocke M; Dierkes K; Decristoforo C; Oberladstätter M; Kolbitsch C; Zschiegner F; Riccabona G; Poewe W; Wenning G
    Neuroimage; 2002 Sep; 17(1):128-41. PubMed ID: 12482072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT.
    van Dyck CH; Seibyl JP; Malison RT; Laruelle M; Wallace E; Zoghbi SS; Zea-Ponce Y; Baldwin RM; Charney DS; Hoffer PB
    J Nucl Med; 1995 Jul; 36(7):1175-81. PubMed ID: 7790941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Baldwin RM; Zoghbi S; Zea-Ponce Y; Charney DS; van Dyck CH; Hoffer PB; Innis RB
    J Nucl Med; 1997 Sep; 38(9):1453-9. PubMed ID: 9293807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPECT-evaluation of the monoamine uptake site ligand [123I](1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane ([123I]beta-CIT) in untreated patients with suspicion of Parkinson disease.
    Eising EG; Müller TT; Zander C; Kuhn W; Farahati J; Reiners C; Coenen HH
    J Investig Med; 1997 Oct; 45(8):448-52. PubMed ID: 9394097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease.
    Ahlskog JE; Uitti RJ; O'Connor MK; Maraganore DM; Matsumoto JY; Stark KF; Turk MF; Burnett OL
    Mov Disord; 1999 Nov; 14(6):940-6. PubMed ID: 10584667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease.
    Scherfler C; Seppi K; Donnemiller E; Goebel G; Brenneis C; Virgolini I; Wenning GK; Poewe W
    Brain; 2005 Jul; 128(Pt 7):1605-12. PubMed ID: 15817519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of [123I]beta-CIT and [123I]IPCIT as single-photon emission tomography radiotracers for the dopamine transporter in nonhuman primates.
    Scanley BE; al-Tikriti MS; Gandelman MS; Laruelle M; Zea-Ponce Y; Baldwin RM; Zoghbi SS; Hoffer PB; Charney DS; Wang S
    Eur J Nucl Med; 1995 Jan; 22(1):4-11. PubMed ID: 7698153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.
    Staley JK; Krishnan-Sarin S; Zoghbi S; Tamagnan G; Fujita M; Seibyl JP; Maciejewski PK; O'Malley S; Innis RB
    Synapse; 2001 Sep; 41(4):275-84. PubMed ID: 11494398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
    Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
    Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-beta-CIT SPECT data.
    Ichise M; Kim YJ; Erami SS; Ballinger JR; Vines D; Tanaka F; Lang AE
    J Nucl Med; 1999 Apr; 40(4):530-8. PubMed ID: 10210210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.